We are live on
!
Find out more
ICP
Ilex Capital Partners Portfolio holdings
AUM
$4.06B
1-Year Est. Return
6.11%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
-6.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.48B
AUM Growth
+$509M
(+52%)
Cap. Flow
+$382M
Cap. Flow
% of AUM
25.7%
Top 10 Holdings %
Top 10 Hldgs %
66.73%
Holding
34
New
14
Increased
7
Reduced
4
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$209M |
| 2 |
Alcon
ALC
|
+$119M |
| 3 |
Clorox
CLX
|
+$67.2M |
| 4 |
Bunge Global
BG
|
+$57.5M |
| 5 |
Linde
LIN
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$109M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$80.6M |
| 3 |
Constellation Brands
STZ
|
+$65.7M |
| 4 |
Campbell Soup
CPB
|
+$53.3M |
| 5 |
LyondellBasell Industries
LYB
|
+$52.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 55.45% |
| 2 | Materials | 28.09% |
| 3 | Healthcare | 15.5% |
| 4 | Consumer Discretionary | 0.96% |
Similar funds
CA
MGP
BWA
JSW
AI
BHC
CG
AP
Ilex Capital Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Ilex Capital Partners held 34 positions worth $1.48B, up 52% from $976M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Ilex Capital Partners deployed $382M of net new capital in Q3 2024, opening 14 new positions and adding to 7 existing holdings. Its largest new stake was Mondelez International: 2,973,324 shares worth $219M.
By sector, the portfolio is most concentrated in Consumer Staples at 55% of assets, down from 56% a quarter earlier, followed by Materials and Healthcare.
On the sell side, the largest reduction was Coca-Cola, an estimated $109M trimmed.
- Ilex Capital Partners's largest Q3 2024 buy was Mondelez International: 2,973,324 shares worth $219M.
- Ilex Capital Partners added most to Clorox in Q3 2024, an estimated $67.2M increase.
- Ilex Capital Partners's biggest Q3 2024 reduction was Coca-Cola, cutting an estimated $109M.
- Ilex Capital Partners fully exited Thermo Fisher Scientific in Q3 2024, selling an estimated $80.6M.
- Ilex Capital Partners's ten largest holdings make up 67% of its $1.48B portfolio in Q3 2024.
- Ilex Capital Partners opened 14 new positions and closed 9 in Q3 2024.
- Ilex Capital Partners's portfolio value rose 52% quarter-over-quarter to $1.48B.
Based on Ilex Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.